Agenda

Return

C. 44

To:	Board of Supervisors
From:	William Walker, M.D., Health Services Director
Date:	December 13, 2016

Contra

Costa

County

Subject:

Amendment to Purchase Order with Beckman Coulter Inc.

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 12/13/2016

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

John Gioia, District I Supervisor
Candace Andersen, District II Supervisor
Mary N. Piepho, District III Supervisor
Karen Mitchoff, District IV Supervisor
Federal D. Glover, District V Supervisor

Contact:	Anna Roth, 925-370-5101
cc:	Tasha Scott Marcy Wilhelm Crystal Grayson

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: December 13, 2016
David Twa,

BY:	, Deputy

RECOMMENDATION(S):

Approve and authorize the Purchasing Agent, on behalf of the Health Services Department, to execute an amendment to the purchase order with Beckman Coulter Inc. to add $2,200,000 for a new total payment limit of $2,917,667 for the rental of immunoassay analyzers and supplies and reagents for the Clinical Laboratory at the Contra Costa Regional Medical Center (CCRMC) and Contra Costa Health Centers, with no change in the original term of May 15, 2013 through May 14, 2019.

FISCAL IMPACT:

100% funding is included in the Hospital Enterprise Fund I Budget.

BACKGROUND:

The Clinical Laboratory at CCRMC needs to rent immunoassay analyzers. It also needs to purchase Remisol middleware, supplies, and reagents for the analyzers. The Health Services Department uses the analyzers to perform various chemistry tests for patients of CCRMC. The current analyzers were purchased back in 2006 and are now past their useful life. The new equipment will allow the Department to use current technology and cut down on false test results which leads to less manual intervention.

BACKGROUND: (CONT'D)

When the original purchase order was established, it only accounted for the first year's costs of $717,666. The equipment was installed earlier this year. The department will continue to utilize the equipment through the end of the purchase order's term of May 14, 2019, which results in the need to increase the purchase order by $2.2 mil.

CONSEQUENCE OF NEGATIVE ACTION:

If this Purchase Order is not approved the Clinical Laboratory will be unable to perform patient testing, thus impacting patient care.

CHILDREN'S IMPACT STATEMENT:

Not applicable.